glp 1 for mcas Not all GLP-1s work the same way MCAS. Most patients do better on Tirzepatide, the dual incretin with both GLP-1 and GIP receptor agonists. But some mast cells just respond better Mast Cell Activation Syndrome (MCAS)

In a large Swedish study published in JAMA Psychiatry in November 2024, scientists found that people who were taking the GLP-1 drugs semaglutide or liraglutide were less likely to be hospitalized for AUD

Doctors may prescribe GLP-1 treatment for people with a body mass index (BMI) above 30 or those with a BMI of 27 or higher with preexisting conditions

Missing two consecutive doses is more serious

Not intended for human or veterinary use, consumption, administration, or diagnostic purposes

State employee plans and federal employee plans often have better coverage than individual market plans

The researchers studied the frequency of alopecia in adults with type 2 diabetes taking GLP-1 drugs, compared with those taking SGLT-2 inhibitors or DPP-4 inhibitors